The NK cell receptors involved in tumor cell killing include the HLA class I-specific inhibitory receptors (i.e. KIRs and CD94/NKG2A) and major activating NK receptors (including NKp30, NKp46, NKp44, NKG2D and DNAM-1). This evidence concerns the gene KLRD1 and neoplasm.